MedTrace Logo

Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy

NCT05866458 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 352

Last updated 2026-06-17

No results posted yet for this study

Summary

To de-escalate radiation therapy in women with breast cancer.

Conditions

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Hamilton Health Sciences Corporation

    collaborator OTHER

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Elena Parvez, MD · Juravinski Cancer Centre

  • Thierry Muanza, MD · Jewish General Hospital

  • Mark Basik, MD · Jewish General Hospital

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-12
Primary Completion
2031-10-31
Completion
2031-10-31

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05866458 on ClinicalTrials.gov